MAPT and tauopathy: Despite the conventional wisdom that these biomarker changes would typically be associated with a decline in clinical function, the increased levels of both tau phosphorylation and tauopathy propagation in MAPTP301S;Tyrobp-/- mice were accompanied by improvement in both clinical and electrophysiological functions.